BioCentury
ARTICLE | Clinical News

CroTAb rattlesnake antivenom regulatory update

November 22, 1999 8:00 AM UTC

PTI said that the FDA has requested supplemental data to validate the manufacturing process for CroTAb to support the company's ELA for the product, which is under review. PTI said that while the issu...